Evidence map›Paper›PMID 29925924›Full record

ReviewNature reviews. Neurology2018

Neuroimmune disorders of the central nervous system in children in the molecular era.

Elizabeth Wells, Yael Hacohen, Amy Waldman, Jan M Tillema, Ariane Soldatos, Beau Ances, Susanne Benseler, Bibi Bielekova, Russel C Dale, Josep Dalmau and 12 more

Erratum issuedAbstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Neurology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Mechanisms of Cadmium Neurotoxicity.International journal of molecular sciences · 2023
    Review
  8. Review
  9. Observational
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Narcolepsy risk and COVID-19.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2020
    Article
  16. Possible clinical role of MOG antibody testing in children presenting with acute neurological symptoms.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2020
    Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors.

Elizabeth WellsCenter for Neuroscience and Behavioral Medicine, Children's National Health System, Washington, DC, USA.
Yael HacohenDepartment of Neuroinflammation, Queen Square MS Centre, UCL Institute of Neurology, London, UK. y.hacohen@ucl.ac.uk.
Amy WaldmanDepartment of Neurology and Pediatric Multiple Sclerosis Clinic, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Jan M TillemaDepartment of Neurology, Mayo Clinic, Rochester, MN, USA.
Ariane SoldatosNational Institute of Neurological Disorders and Stroke, NIH, Bethesda, MD, USA.
Beau AncesDepartment of Neurology, Washington University in St. Louis, St. Louis, MO, USA.
Susanne BenselerSection of Rheumatology, Department of Pediatrics, Alberta Children's Hospital, Calgary, Alberta, Canada.
Bibi BielekovaNeuroimmunological Diseases Unit, National Institute of Neurological Disorders and Stroke, NIH, Bethesda, MD, USA.
Russel C DaleInstitute for Neuroscience and Muscle Research, Kids Research Institute at the Children's Hospital at Westmead, University of Sydney, Westmead, New South Wales, Australia.
Josep DalmauICREA-IDIBAPS, Hospital Clínic, University of Barcelona, Barcelona, Spain.
William GaillardCenter for Neuroscience and Behavioral Medicine, Children's National Health System, Washington, DC, USA.
Mark GormanDepartment of Neurology, Boston Children's Hospital, Boston, MA, USA.
Benjamin GreenbergDepartment of Neurology and Neurotherapeutics and Department of Pediatrics, University of Texas Southwestern, Dallas, TX, USA.
Ann HyslopDepartment of Pediatric Neurology and Epilepsy, Miami Children's Hospital, Miami, FL, USA.
Carlos A PardoJohns Hopkins Transverse Myelitis Center, Baltimore, MD, USA.
Robert C TaskerDepartment of Neurocritical Care, Boston Children's Hospital, Boston, MA, USA.
E Ann YehDepartment of Paediatrics, Division of Neurology, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
Amit Bar-OrDepartment of Neurology and Neurosurgery, Montreal Neurological Institute and Hospital, McGill University, Montreal, Quebec, Canada.
Sean PittockDepartment of Neurology, Mayo Clinic, Rochester, MN, USA.
Adeline VanderverDepartment of Neurology and Pediatric Multiple Sclerosis Clinic, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Brenda BanwellDepartment of Neurology and Pediatric Multiple Sclerosis Clinic, Children's Hospital of Philadelphia, Philadelphia, PA, USA. BanwellB@email.chop.edu.
attendees of the International Neuroimmune Meeting

Funding

Multiple Medical Therapies for Pediatric TBI; Comparative Effectiveness ApproachU01NS081041 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BELL, MICHAEL J, WISNIEWSKI, STEPHEN R · 2013 to 2017
$15.9M
Comprehensive multimodal analysis of patients with neuroimmunological diseasesZIANS003055 · NINDS · NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE · PI BIELEKOVA, BIBIANA · 2009 to 2018
$9.0M
Exercise Training to Improve Brain Health in Older HIV+ IndividualsR01NR015738 · NINR · WASHINGTON UNIVERSITY · PI ANCES, BEAU M · 2015 to 2019
$3.0M
Environmental and genetic risk factors for pediatric MSR01NS071463 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WAUBANT, EMMANUELLE LAURENCE · 2010 to 2015
$2.8M
Frailty and Brain Integrity in Older HIV-infected IndividualsR01NR014449 · NINR · WASHINGTON UNIVERSITY · PI ANCES, BEAU M · 2013 to 2017
$2.4M
NEUROIMAGING AND NEUROBEHAVIORAL BASIS OF RISKY DECISION-MAKING IN ADOLESCENTSR01NR012907 · NINR · WASHINGTON UNIVERSITY · PI ANCES, BEAU M · 2011 to 2015
$1.9M
CNS Demyelinating Autoimmunity Targeting Water Channel ComplexesR01NS065829 · NINDS · MAYO CLINIC ROCHESTER · PI PITTOCK, SEAN JOSEPH · 2010 to 2014
$1.7M
Development of visual and neurologic outcome measures in pediatric MSK23NS069806 · NINDS · CHILDREN'S HOSP OF PHILADELPHIA · PI WALDMAN, AMY TARA · 2012 to 2016
$924k
Noninvasive Determination of Intracranial Pressure in Pediatric PatientsR21NS084264 · NINDS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI HELDT, THOMAS · 2014 to 2015
$445k
NINDS NIH HHS K23 NS069806NINDS NIH HHS R01 NS065829NINDS NIH HHS R01 NS071463NINDS NIH HHS R21 NS084264NINDS NIH HHS U01 NS081041NINR NIH HHS R01 NR012907NINR NIH HHS R01 NR014449NINR NIH HHS R01 NR015738
6 · The paper itself

Abstract

Immune-mediated disorders of the CNS in children are a complex group of demyelinating, inflammatory, parainfectious and postinfectious disorders with heterogeneous pathobiological mechanisms and clinical manifestations, often associated with fundamental derangement in immune regulation. In this Review, we aim to provide an update on our knowledge of neuroimmune disorders and highlight areas of research that are priorities for improving clinical management. We outline the clinical features of neuroimmune disorders, the current approaches to their treatment and new approaches in development. We then consider the pathological features, including biomarkers, pathological mechanisms and genetics, and discuss the value of immune assays in clinical investigation and basic research. On the basis of current knowledge and techniques, we propose four research priorities: rigorous and consistent collection of core clinical data, cooperative investigation of treatments, development of biological assays and genetic studies. These priorities should help us to achieve the shared goal of precision medicine for neuroimmune disorders. However, multicentre research and the creation of clinical consortia for these rare disorders will be necessary, and we hope that this Review serves as a call to action that is timely given current exciting advances in neuroimmune therapeutics.

Indexed as

BiomarkersNeuroimmunomodulationAdolescentAnimalsCentral Nervous System DiseasesChildDemyelinating Autoimmune Diseases, CNSEncephalitisHumansImmune System DiseasesBiomarkers

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.